Skip to content

Levamisole Binding Capacity in Whole Blood

Published: August 9, 2026Updated: August 16, 2026

This test measures how much of a medication called levamisole is bound to proteins in your blood. Levamisole is sometimes used to treat certain types of anemia or parasitic infections.

Quick summary

["This test helps assess how well your body is utilizing levamisole for treatment purposes."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
59291-5
Short code
Levamisole Bld-mCnc
Synonyms
Levamisole Bld-mCnc
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may order this test if you’re receiving levamisole therapy to monitor its effectiveness or check for potential side effects related to how your body processes the medication.

What to Expect Before the Test

No special preparation is typically needed. You may provide a simple blood sample, often drawn from a vein in your arm, depending on the lab’s standard procedure.

What the Results Mean

Results indicate the proportion of levamisole bound to proteins in your blood. Lower than expected levels might suggest how well the medication is being absorbed or metabolized, but exact interpretations depend on clinical context and your treatment plan.

Common Reasons for Testing

This test is often used in research or specialized clinical settings to evaluate levamisole pharmacokinetics or assess its role in managing conditions like autoimmune hemolytic anemia or parasitic infections.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Clinical Significance: Levamisole Binding Capacity

Short name

Levamisole Binding Capacity

Frequently asked questions

What does a low or high levamisole binding capacity mean?
A low binding capacity could indicate reduced protein availability to carry levamisole, potentially affecting its therapeutic effects or leading to side effects like nausea or allergic reactions. High binding capacity may suggest adequate protein levels but doesn’t directly indicate effectiveness without clinical correlation.
How often should I get this test?
Your healthcare provider will determine the frequency based on your treatment plan, symptoms, and response to levamisole. Regular monitoring may be needed if you’re on long-term therapy.
Can I eat or drink before this test?
Typically, you can eat and drink normally unless instructed otherwise by your provider. Blood tests usually don’t require fasting unless specified for other reasons.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy